Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2025-05-26
2025-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim :
1. determine the prevalence and clinicopathological pattern of patients with colorectal cancers
2. interpretative association between risk factors and severity of patient condition to define possible predictors
3. assess potential association between serum markers, imaging, endoscopic features and underlying condition.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Some Risk Factors Associated With Colorectal Cancer
NCT05170360
Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population
NCT01793207
Gut Microbiome and Colorectal Cancer
NCT06748339
Next-generation Sequencing of Colorectal Cancer Somatic Cells to Guide Genetic Susceptibility Gene Mutations Screening.
NCT04280666
A Cohort of Molecular Characteristics and Prognosis of Colorectal Cancer
NCT05086601
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. all data will be obtained from patients as personal history (name, age, sex, occupation,residence , marital status, personal habits), history of illness at diagnosis, presence of diabetes or hypertension and other co-morbidity
2. general examination as general appearance,vital signs ,head and neck ,chest ,upper and lower limbs, Abdomen and pelvis ,and local examination as per rectal examination.
3. laboratory test as complete blood count and tumor markers ,imaging as abdominal ultrasound, CT,MRI, endoscopic findings and pathological features.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with colorectal cancers
Patients more than 18 years old with colorectal cancers
Endoscope
Lower endoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscope
Lower endoscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with confirmed diagnosis of colon or rectal cancer ,supported by histopathological result
Exclusion Criteria
* patients diagnosed with other malignancies rather than colorectal cancers
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Khaled Abdelrahman Elsayed
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed O Ahmed, Lecturer
Role: STUDY_DIRECTOR
Sohag faculty of medicine, internal medicine department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag faculty of medicine
Sohag, Sohag Government, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med--25-5-8MS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.